Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Aronson

Showing results (391-400 of 572) with videos related to

Pageof 58
Sort By:
BJU International|September 24, 2010
A natural history of weight change in men with prostate cancer on androgen-deprivation therapy (ADT): results from the Shared Equal Access Regional Cancer Hospital (SEARCH) databaseHoward S Kim, Daniel M Moreira, Matthew R Smith, et al.
BJU International|March 10, 2018
Obese patients with castration-resistant prostate cancer may be at a lower risk of all-cause mortality: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) databaseAdriana C Vidal, Lauren E Howard, Amanda de Hoedt, et al.
Prostate Cancer and Prostatic Diseases|November 18, 2009
The effect of race on the discriminatory accuracy of models to predict biochemical recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databasesD M Moreira, J C Presti, W J Aronson, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 12, 2017
Predictors of operative time during radical retropubic prostatectomy and robot-assisted laparoscopic prostatectomyRoss M Simon, Lauren E Howard, Daniel M Moreira, et al.
Prostate Cancer and Prostatic Diseases|September 7, 2011
Preoperative weight change and risk of adverse outcome following radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital databaseB M Whitley, D M Moreira, J-A Thomas, et al.
BJU International|October 23, 2018
Obesity, risk of biochemical recurrence, and prostate-specific antigen doubling time after radical prostatectomy: results from the SEARCH databaseStephen J Freedland, Brandee L Branche, Lauren E Howard, et al.
BJU International|April 4, 2017
Thresholds for PSA doubling time in men with non-metastatic castration-resistant prostate cancerLauren E Howard, Daniel M Moreira, Amanda De Hoedt, et al.
Cancer|April 30, 2019
Poorly controlled diabetes increases the risk of metastases and castration-resistant prostate cancer in men undergoing radical prostatectomy: Results from the SEARCH databaseFarnoosh Nik-Ahd, Lauren E Howard, Adva T Eisenberg, et al.
Urology|July 24, 2017
Timing of Prostate-specific Antigen Nadir After Radical Prostatectomy and Risk of Biochemical RecurrenceStephanie L Skove, Lauren E Howard, William J Aronson, et al.
Cancer|October 21, 2015
Is computed tomography a necessary part of a metastatic evaluation for castration-resistant prostate cancer? Results from the Shared Equal Access Regional Cancer Hospital DatabaseBrian T Hanyok, Lauren E Howard, Christopher L Amling, et al.
Pageof 58

Showing results (391-400 of 572) with videos related to

Sort By:
Pageof 58
BJU International|September 24, 2010
A natural history of weight change in men with prostate cancer on androgen-deprivation therapy (ADT): results from the Shared Equal Access Regional Cancer Hospital (SEARCH) databaseHoward S Kim, Daniel M Moreira, Matthew R Smith, et al.
BJU International|March 10, 2018
Obese patients with castration-resistant prostate cancer may be at a lower risk of all-cause mortality: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) databaseAdriana C Vidal, Lauren E Howard, Amanda de Hoedt, et al.
Prostate Cancer and Prostatic Diseases|November 18, 2009
The effect of race on the discriminatory accuracy of models to predict biochemical recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databasesD M Moreira, J C Presti, W J Aronson, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 12, 2017
Predictors of operative time during radical retropubic prostatectomy and robot-assisted laparoscopic prostatectomyRoss M Simon, Lauren E Howard, Daniel M Moreira, et al.
Prostate Cancer and Prostatic Diseases|September 7, 2011
Preoperative weight change and risk of adverse outcome following radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital databaseB M Whitley, D M Moreira, J-A Thomas, et al.
BJU International|October 23, 2018
Obesity, risk of biochemical recurrence, and prostate-specific antigen doubling time after radical prostatectomy: results from the SEARCH databaseStephen J Freedland, Brandee L Branche, Lauren E Howard, et al.
BJU International|April 4, 2017
Thresholds for PSA doubling time in men with non-metastatic castration-resistant prostate cancerLauren E Howard, Daniel M Moreira, Amanda De Hoedt, et al.
Cancer|April 30, 2019
Poorly controlled diabetes increases the risk of metastases and castration-resistant prostate cancer in men undergoing radical prostatectomy: Results from the SEARCH databaseFarnoosh Nik-Ahd, Lauren E Howard, Adva T Eisenberg, et al.
Urology|July 24, 2017
Timing of Prostate-specific Antigen Nadir After Radical Prostatectomy and Risk of Biochemical RecurrenceStephanie L Skove, Lauren E Howard, William J Aronson, et al.
Cancer|October 21, 2015
Is computed tomography a necessary part of a metastatic evaluation for castration-resistant prostate cancer? Results from the Shared Equal Access Regional Cancer Hospital DatabaseBrian T Hanyok, Lauren E Howard, Christopher L Amling, et al.
Pageof 58